Sirdalud MR 6 mg - Kapseln (parallel import EurimPharm Vertriebs-GmbH & Co KG)

Recall | Medicines | 14/07/2023

The parallel distributor and marketing authorisation holder informed its customers on July 14, 2023, that the active ingredient release in the mentioned batches may lie outside the specified limits. This could affect its effectiveness. Therefore, this batch will be recalled as precaution.

Name of the medicinal product Sirdalud MR 6 mg - Kapseln
Marketing authorisation number(s) 1-19584-P2
CIP code 5513023
Marketing authorisation holder EurimPharm Vertriebs-GmbH & Co KG
Batch number(s) Batch, Expiry Date
KER87 (Umpack Ch.-B.: 1000685496), 31.10.2024
KER87 (Umpack Ch.-B.: 1000687393), 31.10.2024
KER87 (Umpack Ch.-B.: 1000695587), 31.10.2024
KFH42 (Umpack Ch.-B.: 1000701689), 31.10.2024
KHU92 (Umpack Ch.-B.: 1000709370), 31.05.2025
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-4391

Further inquiry note